Vincent L.
- Country
- France
- Department
- Service Hepatologie
Research Overview
- A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
- Phase 3 Randomized Double‑Blind Study of MK‑1084 + Durvalumab vs Placebo + Durvalumab in Locally Advanced KRAS G12C‑Mutant Unresectable NSCLC Post‑Chemoradiotherapy
- Evaluation of the Efficacy and Safety of Obeticholic Acid and Bezafibrate in Patients with Primary Biliary Cholangitis Unresponsive or Intolerant to Ursodeoxycholic Acid
Data & Insights
Has run more than one trial at 160 of 382 partner sites.
Specializations
Chronic Liver Diseases
The investigator specializes in treating various chronic liver conditions, with particular focus on primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Their research encompasses therapeutic approaches using bezafibrate and ursodeoxycholic acid combinations.
- PBC Treatment Optimization
- PSC Management Strategies
- Combination Therapy Approaches
Viral Hepatitis Management
Focuses on innovative treatments for chronic hepatitis B and hepatitis D infections. The investigator evaluates novel therapeutic agents including bepirovirsen and bulevirtide, exploring their potential in achieving functional cure.
- Antiviral Therapeutics
- Chronic Viral Hepatitis
- Treatment Response Assessment
Advanced Liver Disease
Specializes in managing complications of liver cirrhosis and portal hypertension. The research includes prevention of esophageal varices and evaluation of treatments for non-alcoholic steatohepatitis (NASH).
- Cirrhosis Management
- NASH Treatment
- Portal Hypertension Therapy
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.